University of Nebraska Medical Center

DigitalCommons@UNMC
MD Theses

Special Collections

1946

Biochemistry of muscle contraction and its aberrations in
nutritional muscular dystrophy
Kenneth Adams Blinn
University of Nebraska Medical Center

This manuscript is historical in nature and may not reflect current medical research and
practice. Search PubMed for current research.

Follow this and additional works at: https://digitalcommons.unmc.edu/mdtheses

Recommended Citation
Blinn, Kenneth Adams, "Biochemistry of muscle contraction and its aberrations in nutritional muscular
dystrophy" (1946). MD Theses. 1364.
https://digitalcommons.unmc.edu/mdtheses/1364

This Thesis is brought to you for free and open access by the Special Collections at DigitalCommons@UNMC. It
has been accepted for inclusion in MD Theses by an authorized administrator of DigitalCommons@UNMC. For
more information, please contact digitalcommons@unmc.edu.

THE BIOCHEMISTRY OF MUSCLE CONTRABTIO�.
AND ITS ABERRATIONS IN

NUTRITIONAL MUbWLAR DYSTROPHY

BY

KENNETH A. BLINN

SENIOR THESIS
1946

Presented to the U�iversity of Nebraska
College of Medicine

Omaha

Table of Contents
Introduction
The Biochemistry of Muscle Contraction
History

General Discussion

The Biochemistry of Common Muscular Dystrophies
Nutritional Muscular Dystrophy and Progressive
Muscular Dystrophy

page
2
4
9
22
28

Summary

43

Bibliography

45

-1-

In trod'..l c ti on
One of the most rapidly advancing fields of biological research in the past decade and a half has been
thc1t of the biochemistry and biophysics of muscular contracti on.

The intense interest of phy s iologists in this

subject has been stimuls_ ted in part ty the fact tl:rnt the
energy-sup plying processes \,; hi ch take p lc-, ce ln muscle
are a pparently funci.amental in the met c:,bolism of almost
a ll other tissues of t h e body (6).

Another inviting

aspect of the study lies in the mechanical properties
of muscle tissue.

Energy expended may be me a sured ei-

ther mechanically, as work, or thermoa.ynamically, as h eat.
A

gain of knowle u.ge has taken place which would have

been considered incredible t wenty years ago •

.Skeletal

muscle has been extensively and fruitf ully analyzed in

its chemistry, gross metabolism, thermodynamics, and
molecular structure.

The result h a s been a correlation

of structural, chemical, and mechanical properties which
far surpasses that for any other tissue.

It has even

been possible to construct, usir;z purified tissue extr2ctives, a synthetic muscle fiber which exhibits all
of thE mechano-chemical pro perties of God's ori s inal
µreduct (17,19,20).

Nearly all of the enzymes hypo-

thec a ted f or tl1e various reactions underlyin -s muscle

-~-

•

contraction have be en isolat ed in pure , many in crystalline, form.
The stt1dy of non-inf e ctious m.yopathies has benefited greatly f r om t he knowledge gained in research on
the biochemistry or contraction.

Clinically, the mus-

cular dystrophies remain at present one or the most
battling groups of diseases, bu t chemical and metabolic
analysis has con e much to clarify the basic pa thology
anu. to suggest pos sib le routes of' t herapy .

Such analysi s

has, in turn, contributed considerably to our knowledge
of normal muscl e physiology, if only by way or ver..i. rica tion through aberration.

01 the m;y opathles , nu tri-

tional musc--1 lar dystro phy i n animals has r·eceived the
greatest amount of attentivn in t h e research laborator~ .
fi'rom a clinical stand.poin t, it is very similar to progressive muscular uystrophy in humans , and the t wo terms
have come to be used al ~ost interchangeably.

Whether

this is justiriea awaits con firmati on.
The purpose of this paper w.ill be to discuss the
biochemistry or n ormal mu scle so far as it; is knolfm and
th en to correlat e it with recent studi es of muscular
riystr o~hies in an attempt to ident i fy the mechanisms or
nutritional dystro phy and to aetermine whether human 1)rogressi ve dystrophy has a nutritional etiolo 6 y.
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His tor·y
The present most widely held concept of th e chemistry of muscle contraction dates 1'r·om the cl&ssical
wor;.-c or· Fletcher and hopKins in 1J07 (1).

Ihey dis-

proved the theory, pro.1c1o sed by Herillann and Pf'ltlger many
years p reviously, that COi:;:; and lactic actd which apoearea in muscle contracting in an atmosphere of nitrogen
were proauc ts of the brea::-Cdovm of hJ'pothetical n.i.nogen 11 •
'I 'hey showed that such co:1 traction was true.ly anaer::Jb:i c,
ror the CO2 was prouuceG by the action or the lactic a citl
on bicarbonate p resent in the muscl e fluids.

l'urther,

their eAperiments ciemonstrated that oxidation aoes not
occur in muscle in an atmosphere of oxyg en until arter
contraction .is over, and t hat l?-ctic acid .is the substance oxidized. to proau ce co 2 •

A re i, yea,:,s la t sr ,

rlarnas and Mey c: rhoi' identified th,: source of lactic acid
as glyco 5 en.

It was also sho,m by JJ. cy .. rhor that only

about one-fir.th oi the lactic acid. disa 1)pearing in aer obic recovery of muscl 0' is oxid1.zed to ~0 8 and that
glycogen increases at this time.
Thus, the 5 rounawurk tor the
in muscle was laid.

11

carbohydra t e cycle Tl

Glycogen breaKs down in t o lactic

acid in the anaerobic pbase or contracti.QD, and on2firth or t he lactic acid is oxiaizeu to

- 4-

~o~

ana water

in the aerobic phase of ~ygr.y, while thE remaining
four-fifths are resynthesized to glye:o 6 en.

The nature

of t he intermeaiat8 steps in the b~eaKdown ann resynthesis of glycugen remained unkno lm until .l!.;mbd.en, who
had previously sho,m the Importance of inor 5 anic ,hos pha te in mu se:le metabolism , p.coposed a h c:xose-phos .::iha "t e
as the precursor to lactic acid (2; .

~rom this point,

the many complicated st ep s kno !fil tou~y to

ucC Ll r

coly sis v1ere elucidat sd by a number of workers.

in gly -

Their

research 0 s, altho~;h dating rrom 1933, comprise too
great a volume of material to b e recorded here .

Hefer-

ences may be rouna in the excellent reviews by Needham
(3) , Parnas (4) ,

t.:eyerhor (5), and t'otter (o).

At the time of ~mbd.en's early work , it was thought
that the immediate source of energy for muscle contraction
lay in 5 lyco 5 en brea~aown .

Oxiaation or lac.:tlc acid was

thought to sup _ply ener 5 y r'or tn e resynthesis

OT

~lycogen .

In 1.327 crea tinephost)hos pha te was discovered si mul taneuusly
by E,ggleton and Eggleton, who nameci it

by Fis.i:ee and. Gubbarow (7,8J .•
(3)

II

phosphalen 11 , c:1.nd

I'wo y ears lat er , Lunds gaard

revealea the i mp ortance or this comp ouna as a source

of energy by noting its decompositiJn into e:reatine and
_phosphoric acid in cont1·a ctj_ng muscle whose carbohya.!'ate
cycle haa been pois0nea by sooium ioaoacet,ate.
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He Jro -

ceeded to show that such a aecomposition occurs in normally contracting muscle bei'Qre t he breakdovm or glycogen
takes place , and that ir the latter 9rocess is pr evented, the muscle ceases ta contract only when creatineohosphate stores are depleted .

Following this discovery, an-

other revisiGn or thought, analogous to that which t ook
place with the discovery or the carbohydra te cycle, occ:irred.

Credit for the immediate energy ror contraction had

been shl1'ted 1'rom oxidation to glycolysis; now it vms
shifted rrom glycolysis to phosphocreatine breakdovm, and
glycolysis, in turn, was thought to supply energy !"or
phos)hocrea tine res:,:n t~esi s.

Bov:cver·, the pie tur-e was as

yet incomplete, for at this time (1929) adenosinetriphosphate vvas discoverea in muscle extracts by Lohmann (10).
He found that its concentration in normally contracting
muscle is nearly constant but that in severe or -prolong ed contraction it breaks down to yield adenylic acid
(acienosine monophosphate) and two molecules 01' phosphoric acid .
1

This splitting is accompanied by the liberatim

0f large amounts or energ;,,·.

It was not until 1934 that

the signir icance of this p:;:ocess in normally contracting
muscle was seen by the same investigator.

Using dialyz-

ed muscle extract, he proved that phosphocreatine cannot
brea;..c down on con traction un. til adenosinetriphos::i11a te
,..

-o-

has broken clown.

It soon became c:, _pc ar ent that the immeci-

iate energy for contraction is supplied by tl--te breakdown
of' adenosinetri 1)ho s phat e , but t ha t Lhe latter is resynth eslzeu simultaneously by _oho s.9hocreatlne breal{down (11) .
,;1ieyerho1' ana .Lo~1mann later i'ounci th[~t

E.

ae:Josi,,.~ctril')hos -

~h2Le is loLj t he sJur~e of ;has ·horus ano L~f ~~er~yrue
for the )hosyhorolysis or 6 1:y cog en , which initi a t es the
c cr1ony urate cycle .

l'he r ole o1: ao.enosinetriphos9hate in

~u s cle me tc; Loli sm has since teen found to be even more

comple.x, but 2;ain , the literature is much too volu mir,ous
to be followec in deta il in this paper .

However , a sim-

ple sche.'.!le for t he chem.i ca:. re a.ct i on s of mJ s'-:le con t1·a ct-

i on can be presented a t this po int and Nil l be ex p~nded
on lc:,.ter, as th ,:., mor e recently kno\'m in te rmedi b te steps
are Jiscussed .
Ls the sti mu lu s for contraction re;:.ches

fTber , acienosinetriphos;:iba te (Al'P) breaks

the muscle

00 1,m ,

li berat -

in i energy for con traction and phosphor·i c a ciei :for the
. phos;,)horol)' sis of 6 lycogcn .

Immediately, phosphocreat-

ine b reaks d.0 :m to SU .Jply energy and phos ) hate ror t h e
1

resynthesis

or

~TP.

Glycolysis, having been initiated ,

proceeas with the proa.uction of lactic acic_ for oxidation

and of energy and reli1:::erated phosphate 1'or the resynthesis or phosphocreetine from creatine .
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Op to this

point , contraction or the anaerob:c phase has occurred .
The aerobic phase of recovery beglns with the oxiaation
of one-fifth o1 the lactic acia to proa'.lce ener.;y f"or
the resynthesis of the remaininJ four-fifths to glycogen .
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Discussion
In reviewing the modern concept 01' muscle biochemistry, it will be expedient to preserit iirst some
aiagrams sl1owin 6 all or the .1:movm rea<..;tions anci then to
correlate these reactions with the simrle scheme outlined above.

Figure I shows the Meyerho1' scheme ror gly -

c..:olysis, moui:t'ieci t;;o incluae recent 1'inaings as suggested by Potter (6).

Fi~ure II shows the Krebs citric acid

cycle, moJi1ied to what may be called the tricarboxylic
acid C}Cle, as suggested by ~rebs himselr (12).
Consioering the glycolysis scheme, the first step
is the break:dovm of ATP by adenosinetri.phosphatag in the
presence 01' calcium ions to yield edenosinediphospha te
(ADP) and phosphoric acid.

The latter is used ror the

phosphorolysis of glyco 6 en , which is catalyzed by phosphorylase in the pres ence at' adenylic acid.

The result

o1 this reaction is glucose 1-phosphate (d(+; 1-phosphoo..-glucopyranose) .

In the presence o:r phOS_!)hoglucomu tase

and magnesium or manganese ions,

the phos ohate group

unaergoes an in tramolecular shift to produce glucose 6phospha te (u(+) 6-phos phogluco pyranose; this compouno
is then changeQ to fructose 6-phos~hate by the enzyme
phosphohe.M?.§.§ isomerase.

The fructose 6-phos i) hate (d(+)~

-.:,'"'

6-phosphoi'ructor'ur·anose) then calls U)On 1,_TP 1·or more
_phosphori e; acic, which is su ~> ;Jli ea through the rneuia tion
of an enz.yme not yet isolated .

·r he products or this

phosphorylation are fructose 1,6-diphosphate (d(+) 1 , 6diphosphofructofuranose) and adenosinediphos_i:1ha te.

Un-

uer the influence of £ymohexase the iormer compound is
split into an equilibrium ml:xture or 3-phosphoglycerc:.ldehyd.e and phosphociihydroxya.cetone .

The e quilibrium is

established by the action of phosphotriose isomerase, and.
phos;1ho<iihydro:x)ace tone predominates until the reaction is
shifte u to the left ty the removal of 3-phosohoglyceraldehyd.e in the i"ollowing step .

3- phosphogly ceralcehyde is

oxidiL,ed by dehydrogenation and takes on another molecule
or' phos phoric ac:ici, from tbe A'rP first broken down , to
form an acyl-phosphate bond.

rhis is catalyzed by phos-

phogJ,yceraldehyde dehyg.rog.§nase anu coen~yme I, the latter
being reau ced by accepting one a tom of hydrogen 1'rom the
3-phosphoglyceraldehyQe and one from the phos J horic acid
molecule .

The products of this important reaction are

1,3-diphosphoglyceric acid and dihydrocozymase.
The next step is the first of two in which energy
is given oft' by the carbohydrate cycle .

1,3-aiphospho-

glyceric acid is broken at the acyl bond by a suitable
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enLyme to ·y ield phosphoric acia to ad.enosinediphosphate .
The products are ATP anu 3- ~J hosphoglyceric acid .

Phospho-

6_1:yceromu tase causes an intramolecular shirt or the phospha te grou~ of the latter compound to iorm 2-Jhosphoglyceric acid.

This, under the influence of enolase is con-

verted to (enol)-phosphopyruvic acid.
energy-releasing . step occurs:

Here, the second

(enol)-phosphopyruvic acid

donates more phos phoric acia. to ADP in the presence o.r a
suitat:e enzyme

ano

magnesium and potassium ions.

proat.1cts, of course, are ATt-' and pyruvic acid.

The

The lat-

ter is possibly in part (4/5) reduced. to lactic acid by
hyarogen from the dit.ydrocozymase formed above anei in
part ·(1/5) used directly in the Krebs cycle of oxidation .
The Krebs cycle will be discussed later.
Ihe assumpti0n ot a nsui table enzyme 11 oc.:c:urs three
times in the glycolysis scheme sho wn .
is necessitated in step V (see Figure

Such an assumption
I)

by the fact that

@osphorylase will not catalyze the phosphorylation or
a ruonosacc hariae.
as coenzyme;
as yet .

In steps lX ana .XII .ADP is reouired

the enzymes simply have not been isolated

The presence of' ADP in these two ste-:-) s d emon-

strates the important point that the glycolysis scheme
does not supply energy and phosphoric acid directly to
creatine for the r esynthesis of phosphocreatine, as sug-
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g E: sted in the previous section of this paper, but rather
through the intermediary of ATP.
Thus, it is eviuent that ATt' does not have the sole
fu n ction of supplying energy for muscle contraction.

The

accumulation of inform&tion about its activities in muscle
e:ontraction

and

many oth(H metabolic p.cocesses in other

tissues has sho~n that it is an ubi qu i tous _carri er or
transport mechanism, as well as tempor a ry storehouse, ror
energy and phosphoric acia .

Now, in the ca_se or muscle ,

at least, phos phocreatine , may be thou ght of a s a station ary or perma,nent 1'eservoir or" these sta ples.*

But the

plural should not be used, for Lipmann (1 3) has emphasiz,ed that thE: energy and the phosphate of ATP alway,;:; .· go
together·, the energy lying in bhe "energy-rich phosphate
bond".

An

en ergy-rich phosphate bond, desi gnated as

rvt'

by Lipmann, is one containing from 9 , 0J) to 11,00) cal*As has been mentioned, the phos phocreatine store may be
de pleted or resynthesized according to the needs or the
tissue, but the concentration of ATP r emains relatively
constant.

l'his relationship is expressed by the e quil-

ibrlum, f: pho s ~hocreatine

+

actenylic acio(

a.s suggestea by Lohmann in 1934 lll), or,
ATP~ crea tine<

➔ ALP+

phospho c.;rea tine.

- li:::-

>~ c:r eatine +AI't',

ories of energy per mole of phosphate.

l,ompounds contain-

ing such bonas are ATP, phosphocreatine, 1,3-diphosphoglyceric acid, and (enol)-phosphopyruvic acid.

Phosphate

ester bonds, as found in glucose 1-phosphate, 3-phos phoglyceraldehyde, phosphodihydroxyacetone, etc., contain
only 2, J00-4, 000 calori8s of energy per mole.

The phos-

phorylation of an alcoholic hyaroxyl group to form a phos pha te ester linkc:ge requires energy, which is reaciily
supplieu by t he energy-rich bond resiuing in ATP.

The

formation of ener gy-rich phosphate bonds, however, requir·es all of the energy present in another such bond (as in
the case of synthesis of ATP from phosphocreatine) or energy from some outslde mechanism .
usea in the glycolysis scheme:

Two mechanisms are

in the ~irsL, a high-en-

ergy acyl-phosphate bond is formed from mineral 9hospho ric acid by the energy inherent; in oxidation (step VIII);
in the second, ~Pis formed I'rom a pre-existing phosphate
ester bond by the 1·emoval of a molecule of water by enol~

(step XI) .

It will be seen that in the whole course

of glycolysis four energy-rich phosphate bonds are rormed, but since one is expendea in the phosphorylation

or

glucose 6-phosphate, the resultin 6 number is three, per
mole

or

glucose I-phosphate.
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The Krebs cycle, illustrate~ in Figure II, has been
widely accepted as the most satisfactory scheme ror the
o:xldation of the enu. proa.ucts or glycoly sis· to carbon
dioxide ana water .

An early theory which led to the pres-

ent one by Krebs supposea that lactic acid is rirst oxidized to pyruvic acia by the removal or two atoms or hydrogen and that two molecules of pyruvic acid then combine
to form a hypothetical six-carbon compound.

This c:::>m_pound

was thought to ~o through a series of reactions whereby
one-ha11· of the molecule is oxidized. to carbon dioxide
and wa t er and the other ha11· i.s set rree as py;ruvic acid
to combine with another molecule or the same in starting
the cyc l_e again.

Krebs (14), in the formulation or his

early cycle , suggested.. that the hypothetical 6-carbon co'!:pound is citric acici and that it is rormed not rrom two
mol e eules or pyruvic acid bu t :rrom one 1nolecule of oxalace t ic acid (the end-product of the cycle) and one molecule of a triose de1,ivative, probably >Jyruvic acid.

Lat-

er experim ents proved, however, that citric acid is not
in the direct path of the cycle but is formed by a collateral equilibrium with cis-aconitic acid.
modern

11

Hence, the

tricarboxylic acid" cycle of Krebs.*

*It should be noted that there is no necessity 1·or assum-
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Thou 5 h the compounds in this cycle have not been
isolateu in phosphorylated rorm, it is pxouable that
phosphorylation is an integral part or the proces s, for
inor 6 anic phosphate is necessary for its r:.mctioning.
More specifically, Ochoa (15) has demonstrated that the
oxiaation of ~-ketoglutaric a cid rails in the absence
of phosphate.
The energy
or glycogen.

or oxidation is used in the resynthe sis

As the glycolysis scheme shows, all of the

reactions rrom glycogen to lactic acid are reversible;
up to a short tlme ago, this reversibility had been veri1'ied.experimentally in all but one----the splitting ot·
(enol)-phosphopyruvic acid.

It was thought that this

terminal reaction could not reverse through a simple
equilibrium reaction, and so one or two theoriP-s wer e
proposed tJ explain its reversal in a detour
steps.

or

several

Very recently, however, Lardy and ~ie~ler (16)

have proven by the use of raaioactive phosphorus that
the resynthesis of phosphopyruvate is a direct enzymatic reaction, takin g place in the presence

or ATP.

iiig that the portion or pyruvic acid destined for oxidat-

ion ever gets to the lactic acid stage.

directly as pyruvate.
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It may be used

The importance of aaenosinetriphosphate breakdo,-vn ,
in supplying the immeaiate energy ror contraction and in
initiatin~ glycolysis anu respiration , has been emphasiz ed several ti rnes .

1'hi s breakdovm is dependent u1)0n the

action or auenos,i:rr~tf::iphosphatase .

In 1941 , En 6 leharat

(17) published the results of some rernarKable work concerning the natt.11·e or this enzyme .

Through a series of eYp eri-

men ts in purification an-.1. in& eti vation o.r Al'l:-'-a.se prepa1·a tions , he proveci that the enzyme is either

identie;[➔ l

with or inseparable from myosin , a protein comprising 4.J
per cent of all muscle protein and imov,n to ha :rbo:r the
contractile properties 01· the muscle riber .

F'urthermore ,

he showed that artiricic:l :nyosin threads , rormed arter
the method of vveber (18) , exhibit a lengthening or increase
in extensibility when placed in a solution or adenosinetriphosphate.

No other substances tried would repla~e the

latter in prou.ucing this eft"ect .

Englehardt concluded

that myosin is not only the enzyme ca tBly zing the reaction prouucin 5 energy for contraction but is also the
transforl.Iler Ahic.:h converts t ha t energy to mechanic8.l

'NOl'.t{ .

His results were conrirmed by Needham ( 19) and Szen t-Gy~rgyi (2J) , anci it was ackno·..-1led 6 ed. tha t the unirication
of the mec: h anical and chemical events in muscle c.:ontrac.:tion had at last begun .

t~rther observ ation has led to

-16-

the i"inciing that myosin threacls set up in the fashion or
En 6 lehar6.t will contract when calcium ion s are added to
the solution o.f acienosinetriphos_;)~'late (21 , 22).

Calcium

having thus been identified as the acti.va tor· or ATP-ase,
the earlier 'illowleu. 5 e that calcium ions are liberated at
tne time of stlmulation of muscle tissue becomes signiricant (23,24).

This is in accordance .vith the disclosure

or Heilbrunn and his students that stimulation releases
calcium rrom an organic complex in a number or dirrerent
tissues (incluaing muscle) (~5).

That the production or

acetylcholine at the motor ena-plate, or the intr-'.)ductiori
of this compound. into muscle ana gangl:i.on extracts re-

sults in an increase in calcium ion cone en tr&tion has been
Kn.o"\'m i'or some time (26).

Consequently , another uniri-

cation of knowledge has occurred, in that the chemistry
01· the nerve impulse and the chemistry

or muscle contract-

ion have joined into a continuous process throu 6 h the in tercession or calcium.
In an attempt to conciliate the mechanical ana
chemical changes in the myosin molecule during contraction, Binxley (27) has recently proposed a theory basea
upon certain kno ,rm characteristics or Lhe str-ucture 01'
tne m,Jlecule .

The myosin molecule has been acceptea ror

-17-

some time to be elongated or micellar in shap e (18,SS).
Binkley visualizes the contracted stat e as one wherein
t here is a condensation between sul.t"hy Jryl anci hyciroxyamino acio siue chains, resulting in a thio-ether linkac::; e .

The relaxed state is presumed to be brou ,=:;h t a!)ou t

by the ph0sr1horylation or such a linkage with the prod.uc tion of the original sul1"hydryl group ana. the hydroxyamino
acid group in phosphorylatea forill.

Adenosinetriphosphate

would be the phosphorylating agent which cleaves the thioether linkage.

Einkley 1 s diagram, reproduced in Fig~re

III, shows that considera ble shortenin ? of' the myosin
molec.-ule would result from such a reaction 11· the sulrhyaryl and phosphorylated hydroxyamino acid groups were
suitably situated in the polype_p tide cha i n.

'r he energy

for contraction is liberated from these groups when the
thio-ether pattern is 1"ormed.
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·rhe biochemistry
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Gomrnon Muscular LJystrophies

In discussing the subject of nutritional muscular
dystr·ophies, one natu1·ally is expected first · to de1'ine
the term .

As the remainder of this paper will reveal, a

definition of the category requires consiaeration or r ecent facts which actL1ally tend ·to disprove the existence
of such disease entities in humans ~nd to limit the category to one specific pathology in animals .

The one myo-

pathy in &nimals which is tenovm to have a nutritional
etiology is identical in all respects, except response to
trea.tmen t, to progressive muscular dystrophy in humans .
Therefore , this disease shall receive most or the at tention given to the problem in the rollov,ing pages.
The 6 reat body

01'

work done on metabolism o:.: non-

enfectious muscle diseases in general shows that almos t
all have a common characte r istic :
ana creatinine metabolism.

an upse:t ln creatine

Hence, it will be meet to

consiaer each oi these diseases separately so that common etiological factors may be recognized i f t~ey exist .
The diseases are listed , e.long with their characteristic
changes in creatine-creatinine metabollsm, in the chart
of Figure IV.
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Myasthenia Gravis
It is now commonly accepted that the cause of myasthenia gravis is a disturbance · in acet;, lchol ine metaboli sw, whereby this substance is prevented 11·om acting
at the myoneural junction by a cu1·are-like substance ( :.:,9) .
Creatinuria , low creatinine ou t _;m t, and low er ea tine tolerance, when they occur in this disea s e , are belJ eved due
secondarily to destruction or muscle tissue or mar&ed
alteration or metabolism in very severe cases.

It has

been emphasized that uncomplicated myasthenia gravis is

not associated with a...~y chan~e in the fundamental chemistry of muscle contraction. ·
Ivlyotonia Gongeni ta
Myotonia congenita (Ihomsen's disease) is apparently the converse 01· myasthenia gravis .

It is supposedly

caused by an increase of acetylcholine at the motor endpla~e.

However, there are two aerinite changes in

creatine-creatinine metabolism in this myopathy .

High

retention of administered creatine and complete absence
of creatin e excretion , even in children (in whom it is
physiologlcal) , are characteristic.

~uinine is the most

effective therapeutic a 6 ent in reciuc.ing the hyperactivity
•
of muscle in this condition •
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Myotonia Atrophica
Eno.ocr·ine dysfunction is of great importance in
myotonia atrophica, which is typiried by cataracts, alopecia, and testlcular atrophy as well as muscular atrophy.
~u inin e is al so oi' value in the treatment of thi s kin a
or myotonus, but no increase in muscular st.1·ength fo llo ws
its use.

Histological stuciles show that there are two

distinct pathological processes in this disease:

in-

creased muscle tone without significant change in struct ure, and muscular atrophy with definite destruc tion or
tissue.

Creatinuria , ciecreased creatinine excretion, and

decreased creatine tolerance are probably ctue to the latter of these pro cesses.
Familial ?eriodic Paralysis
hecur1·in8 i"laccici paralysis distinguishes t his disease.

Ihe chanJes ln creatine-creatinine metabolism are

the same as in progressive musl:ular dystrophy, exe;ep t that
creatinine excretion, normally constant, i::; signally
variable.

Both abnormally high and low values a.re round.

During attacks, the serum potassium level drops , and admlnistration of potassium salts orally, or· intravenously
is highly successful _in treatment.

t>otassium absorbed

rrom the intestinal tract is excreted in the urine at an
excessive rate, and hater aiuresis may provoke an attack .

- 24-

Calcium anii magnesium balances are normal in this Cii sor-6.e.c-.
P.eroneal Muscular

F. trophy

Little is kno~TI about this disease .

It is accom-

panied by patholo 5 lcul chan 5 es in the spinal coru and
nerve roots .

These c.; hang es may be primary to the mus -

cular atrophy , in which case the malaa~ c oulu be in cluued in the neYt cate~ory .

Creatine-creatlnine meta-

bolism is essentially normal .
Progress.i ve 1v1u scc1lar Atrop11y
and Seconc'.ta.ry I»'iu s cula,r .Atrophy
This c&teg0r;y encompasses ,-dmost all tnyopathies
which are seconaary to nerve disease .

Amyotro~hic

lateral sclerosis , poliomyelitis , anu peripheral neuritis may be citea as examples .

Pe1·oneal muscular atrophy ,

_progressive muscular a trophy , and sEcondary muscular a t.r·ophies all present the same general type of creatine metabolism .

i\hen the total mass or. must.:le involved ls small ,

the picture is substantially no1·mal .

v1hen destruction of

muscle is extensive , t ypical changes t _ake place :

creatin-

uria becomes prominent, creati.ne tolerance decreases , and
Ci•ea tinine output as well as crea tinine C;oefri ci en t dimin-

ishes .

~ , f:.
-,::,J-

Amy:Jtonia 1..,ongeni ta
As the name implies, amyotonia congenita occurs in
t~e first year of: lii'e ana. ls identli'ied by small, ,'lieak
muscles.

However , there is no true atrophy .

La~k or the

normal concentration of anterior horn cells ln the spinal
cord. may be the c:&u se; ir it is, a tru 1Jhy has occurred only
in the po tential sense .

Creatinine output is _.:J&t;hologic-

ally low, and creatinuria is · raised proportionally above
the physiological level for lnra.nts.

rolerance to e:xo-

genous creatine is lacking .
Of the aiseases mentioned , the following have been
pre> ven to be heredi tot"amilial:

myotonia corigen i ta , myo -

tonia atrophica, p rogressive muscular dystrophy , ramilial
pe ri odic paraly sis, i'.)eroneal muscular atrophy .

The use

of glycine (aminoacetic a ciQ) in th erapy or the myopath-

ies will be taken up in th e aiscussion or progre ssive
muscular dystrophy below .

F'or rereren ces to the liter-

ature aric... further information concerning 6.i se&ses 01' muscle, the reader is referred to Biochemistry
by -BodRnst<:y and BoaanSKJ' (DO) .

: , ra
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or

~_iseci,§§

~yasthenia Gravis
!viyotonia l,on 5 eni ta.
Myotonia Atrophica
(Dystrophica Myotonlca)
rrogressive Muscular Dystrophy

l,reatine
Toleranc§

limscle
Crea tj_ne

01':i.ne
Urine
Crea tine -~I.!2B.tin in.e

normal

normal

normal .,._I
or sl. ·

sliGht 1
.J,.

norma l

none

normal

i
t
t

sli 5 ht _

I

Familial Periodic Paralysis

T

l

1'

I

-l,

t

i

normal

normal

none or

I
I\~

-...1
I

1.)Proneal ;_iJluscular At1·ophy
(Charcot-karie-Tooth)

J
'i

or I
( 1· lu e;t:rnn t)

normal

normr::.l

?ro 6 ressive l'Jl.uscular Atrophy
normal
(& Secondary Muscular.Atrophy)

normal

,,

Amyotonia Con 6 eni ta
Fi.5:1re lV

normal
-1'

I

normal

l

Nu tri ti.anal ~. iuscular LJys t roph? &
Progressive JiusculPr l..lys tropny
Late in the 13~0 1 s anC in the early lS~J ' s o num-

ber of investi 6 &t·Jrs re:orteu SUL;Cesses ir ti•s t1·eatment
of progressive musculc:1· U.)-Str·.J :hy \'Jith orally &uninis-

rn:_.y

tered glycir,e (Eunino&L;etic ,H:luJ .

c,JntE-n.. oed that

.
.
.
t~ls substance woula cpuse a aecre~se 1n urinEry cre&cine c.:-1u c:.n .tncr-e· .:-=e .iYJ m'Jsc:_e :-rec1 t >-e ( Zl ) .

Jlyctne

is prob2bly one of the im , ort~rt Jrecursors or creatlne ,

End as such its therapeutic crrects in a disease Entail ine loss of Gre&Cine iroill the tissues 0ere ex)lEine~ .

observation , fQr SULSC~uent no rx sho~ed that cl!nical
i..w-.,rovement was ten1i;.,0rar~.- , l;:;sting from three to ro:ir

months .

In fact , in 1J~3 5rard &~6 hls b:socistes

) roved th~t there ls act~Rlly an increase in urine
creatlne

2riu

a decrease ln muscle crec:tine Mhen slyclne

is liven (ZS) .

the amlno aci~ has been trjed in most

oi' the muscular d;ystrophi C's , but the resu],ts hr,ve bEen

largely uisc:oura::_:L1.g excr::9t in the c2se or myasthenia
gravis, ~here it seems to be of some value .
The lmportance of vl t amin E in muscular dystrophy
was first. susoecteu in 1923 by Evc1ns and Burr (o 3 ) .
They ~eprivea laboratory animals

produceci a ~Jecul iar ty pe o.r
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or

[JLral~y

this substance and

sls .

A uec:aae later ,

histolo~ical stu~ics in vlt~min

~

aeficient raLs shofi-

eu th.et the centrr:,l nervous system lesions are ideetical

to tho se of awJotro,nhic l2teral sclerosis and the skeletal rnu::.,cle pathology resPiubles the.it of 11ro 6 ressive mus-

cular d.ystro)hy (34).

Following this ciiscove ry, Bick-

nell (3f.>) attempteG. to treat human -:ffo 6 r·essive rnuscul&r

dystro phy vd. tli vitamin E .

He fe<.i his 1n,tients oriec:i

fresh whole wheat ~erm, 14 ~rams twice ~ail), an6 reported that twelve out ui eiihteen showeG clinic&l Improvement .

lillprovement In &myotrophic later&l sclerosis

claimea by Wechsler
~

eI'm orBlly and.

Ci-

&

short time l~ter.

~hS

~e useo wheat

tocophero 1 acetate both orally and. ir-

tramu scul&r ly (36; .

~ith these flndin~s , rait~ ln vlto-

min E as a speciri~ ther29outic &~eDt bei[n t0 rise .
However , soon arter~~ r6 s &ceaunts of neg&tive results be g&n to enter the li te1·a ture.

?obl an6. E&ethke ( '67)

triea four regimes of oral viternir E therapy on a series
of fifteen cases:

(lJ wheat _sArm oil, (2) mixec.i. natur-

al tocopherols In oil , (3) natural tocooherols in oil
plus thi& mir e hyd.rochl.oriC.e and pyri6.o::,...i~e hydroc.:hlor· -

ide, and (4) dried fresh whole ~bea t ~erm .

TesLs on

muscular s tren 6.th sho ~;ee;. trw t the diseas e prog ress ed unretardea in all fifteen cases.

fhe ye2~ 1340 w&s one

of con1·1ictin 6 beliefs about the value ot vitamin

E,

and

of tbe B complex, which had just been introduced as
another possible aici. in treatment.

rhe a!TirIT;ative

s trnd wr~s taken by Bicknell, wrio hac. success in 17 or
18 p;:, tients treated. Nith

~

o,'... or wheat germ oil glven

in 2 cc. daily doses; Stone , ; bo improved five pet ie~ts
vvi th the some plus vi tarnin B complex and suezested that

t he B comple~ increases t~e effect of vitpmtn E; and
Ln to t)ol &no. &chotland. ,

who had immediate improv emen t .in

two cases &net ~rcidual improvemen t in four cases who were
given vitamin E plus 100-500 mg. of vitamin B6 per week
subcutaneously.

The negati¥e st fnd Nas ta~en by Pohl

ana Baeth1-Ce, mentioned above; Shelden, Butt, ar1 ci ,,oltman,
who s nw no recovery with administration of whea t germ
oil and d.-tocopherol both intramuscularly and orally;
and McBryde and Baker, who found no ·favora.ble confirmation in si:x patients treated_ with wheat germ oil, c;..-tocopherol, and vitamin B6 orslly and intraveno~sly, and
combinations of the vitamin B complex orally.

Very

careful muscular power tests were made in the latter
instance (33). In·l94f, Lubin (39j reported a relatively lar 6 e series of pediatric cases with various muscular
dystrophies.

Seven patients with amyotrophic lateral

sclerosis, nine p2tients with progressive muscula.r dystrophy, five patients with muscular atrophy, and fourteen patients with miscellaneous myopathies were given
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massive doses of synthetic cl-tocopherol.

Thirty-one

became worse during treatment, and four became better;
but melioration of symptoms in the l a tter was proven, by
withdrawal of treatment, to be due to unkno wn factors.
That natural sources of vitamin E and the insoluble
synthetics ( ct.-tocopherol and ct..-tocopherol acetate) are of
no use in the treatment of human muscular dystrophies is
now generally conceded.

Nevertheless, in laboratory an-

imals there has been considerable good fortune with the
use of these substa11ces.

Nutritional (progressive) mus-

culc.r d.y s trophy in rabbi ts may be cured or prevented by
oral administration of d,1-~-tocopherol or its acetate.
Parenteral or subcutaneous routes of administration are
not as effP-cti;e, accoraing to Mattill (40), and do not
work at all according to Eppstein and Margulis, who
employed 5-10 mg. intramuscular injections of the acetate
in olive oil (41).

Mack enzi ~ and McCollum notea that

oral administration of 20 mg. of ~-tocopherol led to a
decrease of urine creatine in dystropbic rabbits but
that the so.me dose parenterally caused no change in
creatine and decreased urine creatinine.

They stated

that injection of massive_ doses cures in some cases and
moderately palliates in others (42).
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In 1936 .Madsen found that in vitro oxygen consumption of skei'etal muscle from vitamin E: deficient guinea
pigs is considerably increased over that of normal muscle (43).

Similar findings were recorded for rats and

rabbits several years later by Friedman and Mat till (44).
Using the ·warburg technique

on

semi tendinosus muscles

from six months old rats whicb were tocopherol-deficient
since weaning, they noted a 40 per cent increase in oxygen consumption.

Thirteen months olc rats who were in

. severe paralysis from this treatment showed a much smaller, but nevertheless definite increase.

Semitendinos-

us muscles of ,~ rabbi ts subjected to the same protocol
underwent a similar elevation of oxygen consumption rate.
These findings have been conflrmed and extended to hamsters by Houchin and Mattill, and to chicks by Kaunitz
and Pappenhei::ner (45,46) .

The latter workers prevented

increased oxygen consumption in unprotected young rats
from vitamin E deficient mothers by giving 1 mg. of
~-tocopherol acetate on the fifteenth day .

Also , they

perceived that muscle exhibiting such an increase early
in the disease remains normal histologically, indicating that the respiratory anomaly represents ab erran,t
metabolism in the muscle tissue itself rather than a
r esu lt of invading connective tissue proliferation.
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This conclusion tallies with t h e fact, mentioned above,
that excessive oxidation is less in advanced stages of
the disease, where paralysis and des t ruction of muscle
have set in.

Dystrophic muscle from hampsters sho ws

the most marked increase in oxygen use----two-and-oneh alf times normal, on the average.

This value approach-

es normal within 27 hours after oral administration of
~-tocopherol and within 4 hours after intravenous injection of ~-tocopherol phosphate, the wat~r-soluble
ester (47).

The l a tte~ compound is also effective on

dystrophic muscle respiring in vitro (48). Hence, it
is not unfitting to assume, with Houchin, that vitamin
Eis the regulator of oxygen metabolism in normal mus-

cle and that its lack lea ds to promiscuous abuse of
oxidative mechanisms at the expense of other mechanisms
in the physiologic scheme.

According to Mason (49),

oxidBtive mechanisms "get out of control'1 in the absence of tocopherols and "allow the muscle to be consumed by its ovm fire 11.

Hou chin, in interpretation of

his own exp eriments, believes that ~-tocopherol is utilized by the tissues only in its water-soluble phosphorylated form.
In searching for the mechanisms through which vitamin E exerts its oxid8tion regulating effect, further
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data on the chemical composition of dystrophic muscle
should be considered.

Morgulis and Spencer, in 1936

(50), analyzed dystrophic muscle for a number of compounds and found significant changes in concentration
of glycogen, acid-soluble phosphorus compounds, creatine, and cholesterol.

Glycogen in muscle froffi rabbits

first showing signs of dystrophy was discovered to be
30 per cent of normal; in moder a tely advanced cases,
it was 24 per cent of normal; and in very severe cases
it was only about 16 per cent of normal.

Total acid-

soluble phosphorus was s.e en to decrease in proportion
to the extent .of degeneration of the muscle.

In cases

where the disease was far enough advanced to manifest
such degeneration, inorganic-P, phosphagen-P, pyrophosphate-P, and undetermined-? were all diminished, but the
rela t ive proportions between them remained the same as
in normal muscle.

This fits the histological picture

of partial fibrosis in nutritional muscular dystrophy;
normal ap pearing muscle fibers are scattered throughout
the mass of inva.ding connective tissue, and acid-soluble
phosphorus is intracellular phosphorus.

However, in

the early stage of the disease, there is an increase in
inorganic phosphorus coincident with the ctecrease in
organic phosphorus.

Muscle creatine was found to be de-

creased in proportion to the degree of degeneration.
Cholesterol was markedly increased.
-34-

Two years later, Morgulis and Osheroff determined
the mineral composition of the muscles of dystr6phic
rabbits (51).

Sodium concentration showed an average

increase of two-and-six-tenths over the normal.

p·ot-

assium concentration was decreased by one-third.
nesium concentration was unchanged.

Mag-

Concentration of

calcium (total) was increased by 500 per cent, on the
average.

In some cases, the increase was as great as

1000 per cent.

In treated and recovered muscle, potass-

i u m ion concentration remained slightly depressed,
sodium ion was increased by about 50 per cent, and
calcium ion concentration was perfectly normal .

In

regard to anions, acid-soluble phosphate was decreased
to one-half of normal in severely dy strophic muscle,
even though the total phosphorus was 11nchan5 ed.

Chlor-

ide ion concentration was elevated to one and ei g httenths of the normal but was approximately normal in recovered muscle.

In summarizing their results, these

workers assumed that the loss of potassium is due to cell
destruction and that the increase in sodium is a compensatory effeet, keeping the total cation concentration
normal.

Also, it is kno~n tha t bot h sodium ion and

chloride ion increase is associated with connective
tissue proliferation.

Disease d rabbits usually re-

t u rneu to normal in six or seven weeks when their diet
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was supplemented with wheat germ .
From the data cited in this section and the previous section, it is obvious that a brief of the chemical and me tabolic anomalies of dystrophic muscle mu st
take into account the distinction b etween early and
late stages of the disease.

In other words, some of

the biochemical changes are due primarily to the cause
of the disease, and others are due secondarily to the
tissue oestruction (replacement fibrosis) which results
from the disease.

But only certain of the data recog-

nize this distinction, and for the most part, a separation of the changes which take place before and
after tissue destruction has set in must be conjectural. The following changes are probably charact eristic
of earlz nutritional (progressive) mu scular dystrophy :
decrease in glycogen, phos phocreatine, adenosinetriphospha te, creatine, creatine tolerance, and urinary creatinine; anu increase in oxygen consum ption, inorganic
phosphate, diffusable calcium, and urine creatine .
These are explained by the "runaway" processes in the
muscle.

Glyco 6 en is not resynthesi2ed as rapi dly as

it is hydrolyzed and burned .

Adenosinetriphosphate

breaks do wn at an excessive rate and furnishes con-
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centrations of adenosinediphosphate and inorganic
phosphate far above the e~uilibrium values for rest•
ing muscle; these compouncis in turn foster t h e immoderate r a te of glycolysis and respiration.

Phos-

phocreatine breaks down too rapidly in an attem~t to
resynthesi~e ATP end thereby contrib~tes to the increase in inorganic phosphoru s.

The creatine pro-

duced, failing to be reconstituted as phosphocreatine,
is e~creted in the urine.

Failure of yhosphocreatine

resynthesis also accounts for diminished creatine
tolerance.

Lowered muscle creatine is explained by

the fact that 60 9er cent of the total creatine in
nor~al muscle is pr esent as phosphocreatine (5J) .
Decrease in excretion of creatinine, a produc t of
normal creatine metabolism, results from abolishment of the latter process .
Most of the changes of late nutritional muscular
ystrophy (especially with the onset of paralysis) are
due to the loss of functioning muscle fibers.

.Morgulis '

statement that inor 6 anic-P, _pb.osphagen-P, pyrophosphate-P , and ~naetermined-P diminish proportionally
from the norm would tend to indica.te that these changes
are due solel2 to cellular degeneration.

However, it

is prob~, ble that because of the high ratio of fi brosed
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fibers to intact but abnormally functioning fibers, the
chandes inherent in the former far overshadow those of
the latter, which &re e;haracteristic of early dystrophy .
The metabolic disturbances of late dystro_phy , except
for i no r ianic-P decrease, are essentially the same as
those of early dystrophy listed above, but thP.y occur
in different proportions.
We may now more directly approach the problem of
how vitamin E controls the oxidative processes in muscle.

The glycolysis scheme, being a chain of e~uili-

brium reactions, shows that the rate of glycolysis , and
hence of oxidation, depends upon the rate of initial
breakdown of adenosinetriphosphate.

Consequently , the

acti.vity of' adenosinetriohos_nb.atas__e is of utmost importance in de termining the oxidative rate.

The act-

ivHtion of ATP-ase by calci~m ions brings to mlnd
:.viorgulis' important finQin 6 of a f,00 per cent increase
in CEl~ium concentration of mu scle deprived of vitamin
E.

That this su;:erabundance of calcium resul ts in

pa.thulogica lly au 5 men ted ATP-ase acti. vi ty is evident
from the chemical flndin 6 s in such muscle.

Thus, we

may Justifiably postula te th&t vitamin E exerts its
inflJence on oxidation through control of calcium
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metabolism.
s wered:

This leav9s only one question to be an-

what is the mechanism by which vitamin E det-

ermines the availability of ionic calcium?
the mechanism may be a very simple one .

In vitro,

Since water-

soluble d.-toco_pherol phosphate effects a "cure" of the
dystro phic process in vitro while insoluble d...-tocopherol and d.-tocopherol acetate do not (48), .it is possible
that the former compound reduces the concentration of
calcium by precipitating it as highly insoluble calcium
~-tocopherol phosphate.

In fact, this salt may qe pres-

ent in the cortex of the normal muscle cell as the metallo-organic complex which breaks down under stimulus
(acetylcholine) to yield calcium ions (25).

Destruct-

ion of acetylchollne by choline esterase would result
in re-precipitation of calcium ions by ~-tocopherol
phosphate.

If the latter were absent, the concentrat-

ion of calcium ions in the interior of the cell would
steadily increase.
In laboratory animals the insoluble toco pherols
are of little or no value in treatment of ·nutritional
dystrophy when administereci parenterally.

They are,

nevertheless, quite effective when given orally.

In

humans they are valueless both orally and parenterally .
The water-soluble phosphate ester, however, is extreme-
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ly potent when injected intravenously in animals---even more effectual than oral c{-tocopherol itself, as
discovered by Houchin and w.attill (47) and confirmed
by Karrer and Bussmann (52).

Yet, t he latter authors

found that the phosphate ester is not hyctrolyzea in
vitro by phosphatase from kidney, serum, or yeast.

An

explanation f~r this has been suggeste-1 by Jacobi (53).
He points out that the ester linka; e may very well embody an energy-rlch phosphate bond.

An enol-like link-

age ( -C=C-OH) is present in the vitamin E molecule.
I

Structurally, n-tocopherol can be considered a substituted phenol, and phenols and enols in general exhi bit very similar chemical proper ties.

Thus, if enol-

phosphate bonds contain high energy levels, the same
must be true for phenol-phosphate bonds.

Such a high-

ener5y bond in vitamin E would not be susceptlble to
hydrolysis by phosphatase · b~t would re quire a more po tent dephosphorylating system----the adenylic acid (AA)
system.

Jacobi proposes the following equilibrium

reaction:
d..-tocopherol phosphate +ADP (or_ffe

~

ct..-toco-o herol + ATP , or ADP) •
f

Under the assumption of this reaction, ~-tocopherol
should be phos phorylated by adenosinetriphos phate in
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•

the organism.
In reference to this last hypothesis by Jacobi,
the . failure of parenteral ct..-tocopherol therapy in animals may be explained.

According to Pott er (6), adeno-

sinetriphosphate is en important participant in the
phosphorylative mechanisms of the small intestine.

If

((..-tocopherol is utilized in the tissues only as the phosphate ester, it may re Quire phosphorylation in the gut
before its therapeutic properties become manifest.

In-

ability of muscle ATP to phosphorylate the parenterally
administered vitamin could be due to lack in this tissue of a suitable bioca talyst, which is present in the
intestine.

Inefficacy of the insoluble tocopherols in

humans may then be attrib~ted to an anomalous ..£Qrf!plete
lack of the biocatalyst.
Treatment of human progressive muscular dystrophy

.

a waits an important investigation: t he oral and parenteral use of c(.-tocopherol phosphate .

If the disease

responds to this substance, then it can be truly classified as a nutritional muscular dystrophy, and its
identity with nutritional dystrophy in animals will be
established.

In the event of failure of vitamin ther-

apy , certain other compounds might be of value.
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Quin- ·

ine, for example, inhibits phosphorylase and phosphoglucomutase in rabbit muscle (54).

In thereby cut-

ting dovm on the rate of glycolysis and oxidation, it
would be of' merit in retarding the abnormal metabolism of dystrophic muscle, providing weakness did not
result from its curare-like action.

These properties

of quinine may be the basis of its success in the treatment of myotonia congenita and myotonia atrophica.

An-

other candidate for trial in progressive dystrophy is
atabrine, which is knovm to inhibit hexokinase from
yeast and parasite preparations, and lactic dehydrogjfilase from parasite and beef heart prepara t .i ons ( 54) •
Any compound which could selectively precipitate or
bind intracellular calcium would, of course, be the
ideal medicine for progressive muscular dystrophy.
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Summary
1.

A resume of established knowledge· and recent

findings in the biochemistry of normal muscle con ,
traction is given, and an attempt is made to mold this
material into a well integrated phy siologic theory.
2.

The human muscular dystrophies that are at present

accepted as definite clinical entities a re reviewed
from a biochemical standpoint wi th an eye to determining
which , if any, have a nutritional etiology.
3.

Progressive muscular dystrophy in humans is dis-

cussed in its relation to nutritional muscular dystrophy in animals.

It is concluded that glycine and

vitamin E in wa ter-insolubl e forms are of no value in
the treatment of human prog ressive dystrophy and that
since this disease has not responded to such treatment, it can not yet be conclusively classified as
"nut ritional ".

It is further pointed out that al-

thou gh insoluble toco pherols can cure animal nutritional dystrophy when administered orally, they are
of little or no use par enterally and in vitro; and
because the soluble phosphat e ester of vitamin E cures
the disease parenterally and in vitro, even more
effectively than insoluble oral toco pherols, it is

-43-

su5gesteo. that this compound be tried in human progressive muscular dystrophy .

Hypotheses for the pos-

sible mechanism of therapeutic action of vitamin E
are presented .
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